---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005109"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:57:44.330140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Technologies sets 2026 Annual Meeting for April 30; proposal deadline Feb 14

## Summary
- Annual Meeting scheduled for April 30, 2026 at company's principal executive offices in San Antonio, TX.
- Special Meeting of Stockholders (Dec 19, 2025) adjourned without business due to lack of quorum; proposals will be included in Annual Meeting.
- Stockholder proposals or director nominations must be received by Feb 14, 2026, ten days after this announcement.
- Details of proposals and proxy statement to be filed with SEC.

## SEC filing metadata
- accession: 0001493152-26-005109
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/0001493152-26-005109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005109
- JSON: https://secwatch.observer/filing/0001493152-26-005109.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.